Encompass Health Corporation EHC NYSE

Encompass Health Corporation (EHC) reported total assets of $7.09B and total liabilities of $3.81B for fiscal year 2025, resulting in total equity of $3.28B.

The company held $145.1M in cash and short-term investments. Total debt stood at $2.71B, with net debt of $2.61B. The Debt-to-Equity (D/E) ratio was 0.83 (moderate).

Current ratio is 1.08, suggesting adequate short-term liquidity. Interest coverage is 8.5x (strong).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (44/100) — Total assets $7.09B and equity $3.28B support the company's competitive scale
• VALUE (52/100) — Debt-to-Equity 0.83 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 70/100 with 3/7 criteria passed.

FMS

Fresenius Medical Care AG & Co. KGaA

$23.21

-2.15%

ALGN

Align Technology, Inc.

$184.69

+2.23%

ELAN

Elanco Animal Health Incorporated

$24.11

+1.05%

SOLV

Solventum Corporation

$69.02

+2.39%

UHS

Universal Health Services, Inc.

$181.95

-0.68%

ENSG

The Ensign Group, Inc.

$198.45

-0.92%

RDY

Dr. Reddy's Laboratories Limited

$13.13

-1.06%

DVA

DaVita Inc.

$149.45

-1.39%